Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.
Androgen receptor (AR) binds male sex steroids and mediates physiological androgen actions in target tissues. ChIP-seq analyses of AR-binding events in murine prostate, kidney and epididymis show that in vivo AR cistromes and their respective androgen-dependent transcription programs are highly tissue specific mediating distinct biological pathways. This high order of tissue specificity is achieved by the use of exclusive collaborating factors in the three androgen-responsive tissues. We find two novel collaborating factors for AR signaling in vivo--Hnf4α (hepatocyte nuclear factor 4α) in mouse kidney and AP-2α (activating enhancer binding protein 2α) in mouse epididymis--that define tissue-specific AR recruitment. In mouse prostate, FoxA1 serves for the same purpose. FoxA1, Hnf4α and AP-2α motifs are over-represented within unique AR-binding loci, and the cistromes of these factors show substantial overlap with AR-binding events distinct to each tissue type. These licensing or pioneering factors are constitutively bound to chromatin and guide AR to specific genomic loci upon hormone exposure. Collectively, liganded receptor and its DNA-response elements are required but not sufficient for establishment of tissue-specific transcription programs.
Institute of Biomedicine University of Helsinki, Helsinki, Finland.
Päivi
P
Pihlajamaa
Biswajyoti
B
Sahu
Lauri
L
Lyly
Viljami
V
Aittomäki
Sampsa
S
Hautaniemi
Olli A
OA
Jänne
D000818:Animals; D002460:Cell Line; D002843:Chromatin / Q000378:metabolism; D047369:Chromatin Immunoprecipitation; D004822:Epididymis / Q000166:cytology / Q000378:metabolism*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects*; D051541:Hepatocyte Nuclear Factor 3-alpha / Q000502:physiology*; D051557:Hepatocyte Nuclear Factor 4 / Q000502:physiology*; D007668:Kidney / Q000378:metabolism*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009919:Orchiectomy; D009928:Organ Specificity; D011467:Prostate / Q000378:metabolism*; D011485:Protein Binding; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000494:pharmacology; D011944:Receptors, Androgen / Q000378:metabolism*; D022021:Tacrolimus Binding Proteins / Q000096:biosynthesis / Q000235:genetics; D013739:Testosterone / Q000494:pharmacology* / Q000502:physiology; D050656:Transcription Factor AP-2 / Q000502:physiology*; D014158:Transcription, Genetic; D000099159:Tacrolimus Binding Protein 5
D002843:Chromatin; D051541:Hepatocyte Nuclear Factor 3-alpha; D051557:Hepatocyte Nuclear Factor 4; D034741:RNA, Small Interfering; D011944:Receptors, Androgen; D022021:Tacrolimus Binding Proteins; D013739:Testosterone; D050656:Transcription Factor AP-2; D000099159:Tacrolimus Binding Protein 5; C496500:Foxa1 protein, mouse; C496593:Hnf4a protein, mouse